Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more) AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Galmed Pharmaceuticals Ltd GLMD

Healthcare Biotechnology
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes... see more

Current News (NDAQ:GLMD)

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting

PR Newswire December 8, 2025

Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH

PR Newswire December 4, 2025

Galmed Issues CEO Letter to Shareholders

PR Newswire December 1, 2025

Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

PR Newswire November 26, 2025

Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine

PR Newswire November 18, 2025

Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro

PR Newswire November 17, 2025

Galmed Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

PR Newswire August 28, 2025

Galmed Announces Digital Asset Management Strategy to Enhance Capital Efficiency and Drive Shareholder Value

PR Newswire August 25, 2025

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH

PR Newswire May 27, 2025
View More News ››

Opinion & Analysis (NDAQ:GLMD)

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

Streetwise Reports April 18, 2019

Biotech Releases 'Unequivocally Positive' Topline NASH Study Results

Streetwise Reports June 13, 2018
View More Opinion ››

Bullboard Posts (NDAQ:GLMD)

Buy buddy buy because it's taking off this morning.

Otherwise it will be FOMO time for you fellas out there today anyway
coolfooldumbguy - November 17, 2025

GLMD....stopped out

it broke the 2 x's tap on the H.O.d Losing trade
Iseneschal - September 17, 2024

GLMD....You can do "the Rug Pull" anytime now Mr. M ; )

My knnes are a shakin.....while the P.O is a Bakin
Iseneschal - September 17, 2024

GLMD......adding to Short position over $13

Cheers !
Iseneschal - September 17, 2024

GLMD.....calling all Chasers ; )

Us Short sellers need a home P.O set up ......leading all you buyers to the "Slaughter House" sec.gov/Archives/edgar/data...
Iseneschal - September 17, 2024

GLMD.....now trading at $11

LoL
Iseneschal - September 17, 2024
View more Bullboard ››

Atlas Salt Inc.

Atlas Salt Inc.

Atlas Salt Inc. engages in the evaluation, exploration and development of mineral properties in Newfoundland and Labrador ...
View More »

Podcasts